Skip to content
Back to Guavy Wire
Stocks

Amgen Shareholder Cuts Stake, Other Hedge Funds Boost Holdings

Instruments
AMGN
Share

Meyer Handelman Co., a financial firm, sold shares of Amgen Inc. (NASDAQ:AMGN) in the second quarter, reducing its position by 4.0%.

The company now owns 111,120 shares of Amgen's stock after selling 4,645 shares during the period.

This reduction makes up 1.1% of Meyer Handelman Co.'s holdings, and the total value of its Amgen shares is $40,238,000 at the end of the quarter.

Other hedge funds have also made changes to their positions in Amgen during this period, including TCW Group Inc., Fulton Breakefield Broenniman LLC, BIP Wealth LLC, and Trifecta Capital Advisors LLC.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc